| 560 |
Inhibition of Funny current (If) leading to Arrhythmias |
Young Jun Kim |
Open for adoption |
2290: Inhibition of Funny current (If)
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 242 |
Inhibition of lysyl oxidase leading to enhanced chronic fish toxicity |
Stefan Scholz |
Open for adoption |
1462: Thiol group of chemicals interact with sulfuhydryl groups of proteins to form thiol adducts
|
2 AOs
|
|
|
| 551 |
Increased Muscarinic M2 Receptor leading to Arrhythmia |
Young Jun Kim |
Open for adoption |
1602: Increased Muscarinic Acetylcholine Receptors
|
1106: Occurrence, cardiac arrhythmia
|
|
|
| 519 |
Cardiac ion channels blockade leading to increased incidence of cardiovascular morbidity and mortality |
Young Jun Kim |
Open for adoption |
2282: Cardiac ion channels blockade
|
1929: Increased incidence of cardiovascular morbidity and mortality in the general population
|
|
|
| 520 |
Retinoic acid receptor agonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
341: Impairment, Learning and memory
|
|
|
| 522 |
Estrogen antagonism leading to increased risk of autism-like behavior |
Kanglong Cui |
Open for adoption |
112: Antagonism, Estrogen receptor
|
2209: autism-like behavior
|
|
|
| 523 |
Retinoic acid receptor agonism during neurodevelopment leading to microcephaly |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
1978: Increase risk, microcephaly
|
|
|
| 525 |
Reduced oligodendrocyte differentiation during neurodevelopment leading to impaired learning and memory |
Ellen Fritsche |
Open for adoption |
4 MIEs
|
341: Impairment, Learning and memory
|
|
|
| 498 |
Increased LCN2/iron complex leading to neurological disorders |
Young Jun Kim |
Open for adoption |
2148: Increased LCN2/iron complex binds to SLC22A17 receptor in neuron
|
2150: Neurological disorder
|
|
|
| 501 |
Excessive iron accumulation leading to neurological disorders |
Young Jun Kim |
Open for adoption |
2149: Increased intracelluar Iron accumulation
|
2150: Neurological disorder
|
|
|
| 532 |
Retinoic acid receptor agonism during cerebellar development leading to impaired locomotor function |
Diana Lupu |
Open for adoption |
2201: Agonism, Retinoic acid receptor
|
2231: Locomotor function. Impaired
|
|
|
| 533 |
Retinoic acid receptor antagonism during neurodevelopment leading to impaired learning and memory |
Diana Lupu |
Open for adoption |
2232: Antagonism, Retinoic acid receptors
|
341: Impairment, Learning and memory
|
|
|
| 8 |
Upregulation of Thyroid Hormone Catabolism via Activation of Hepatic Nuclear Receptors, and Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Katie Paul Friedman |
Open for adoption |
239: Activation, Pregnane-X receptor, NR1I2
|
319: Loss, Cochlear function
|
Under Development |
1.9 |
| 459 |
AhR activation in the thyroid leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 457 |
Succinate dehydrogenase inhibition leading to increased insulin resistance through reduction in circulating thyroxine |
Simon Thomas |
Open for adoption |
2118: Succinate dehydrogenase, inhibited
|
2119: Increase, Insulin resistance
|
|
|
| 458 |
AhR activation in the liver leading to Subsequent Adverse Neurodevelopmental Outcomes in Mammals |
Prakash Patel |
Open for adoption |
18: Activation, AhR
|
402: Cognitive function, decreased
|
|
|
| 450 |
Inhibition of AChE and activation of CYP2E1 leading to sensory axonal peripheral neuropathy and mortality |
SAROJ AMAR |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
|
|
| 451 |
Interaction with lung resident cell membrane components leads to lung cancer |
Penny Nymark |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1670: Lung cancer
|
|
|
| 452 |
Adverse outcome pathway of PM-induced respiratory toxicity |
li qing |
BY-SA |
2007: Non-coding RNA expression profile alteration
|
2008: Chronic obstructive pulmonary disease
|
|
|
| 453 |
Reactive oxygen species and subsequent oxidative stress lead to increased incidence of digestive morbidity and mortality in the general population |
Ruiyang Ding |
BY-SA |
None
|
None
|
|
|
| 454 |
PM2.5-related AOP frameworks on liver diseases |
Zhou Du |
BY-SA |
None
|
None
|
|
|
| 478 |
Deposition of energy leading to occurrence of cataracts |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2083: Occurrence of Cataracts
|
WPHA/WNT Endorsed |
1.89 |
| 481 |
AOPs of amorphous silica nanoparticles: ROS-mediated oxidative stress increased respiratory dysfunction and diseases. |
Hailin Xu |
BY-SA |
1115: Increase, Reactive oxygen species
|
2 AOs
|
|
|
| 482 |
Deposition of energy leading to occurrence of bone loss |
Vinita Chauhan |
BY-SA |
1686: Deposition of Energy
|
2091: Occurrence, Bone Loss
|
WPHA/WNT Endorsed |
1.89 |
| 433 |
hERG channel blockade leading to sudden cardiac death |
Egemen Bilgin |
BY-SA |
2099: hERG channel blockade
|
1964: Sudden cardiac death
|
|
|